Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Treasury Shares (2021 - 2025)

Prime Medicine's Treasury Shares history spans 5 years, with the latest figure at $3.5 million for Q4 2025.

  • For Q4 2025, Treasury Shares changed 0.0% year-over-year to $3.5 million; the TTM value through Dec 2025 reached $3.5 million, changed 0.0%, while the annual FY2025 figure was $3.5 million, 0.0% changed from the prior year.
  • Treasury Shares reached $3.5 million in Q4 2025 per PRME's latest filing, roughly flat from $3.5 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $5.0 million in Q4 2022 to a low of $3116.0 in Q2 2022.
  • Average Treasury Shares over 5 years is $2.6 million, with a median of $3.5 million recorded in 2024.
  • Peak YoY movement for Treasury Shares: surged 73970.51% in 2023, then tumbled 97.58% in 2024.
  • A 5-year view of Treasury Shares shows it stood at $4.6 million in 2021, then increased by 10.14% to $5.0 million in 2022, then dropped by 23.57% to $3.8 million in 2023, then fell by 9.4% to $3.5 million in 2024, then changed by 0.0% to $3.5 million in 2025.
  • Per Business Quant, the three most recent readings for PRME's Treasury Shares are $3.5 million (Q4 2025), $3.5 million (Q3 2025), and $3.5 million (Q2 2025).